|
WO1985004103A1
(en)
|
1984-03-09 |
1985-09-26 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants
|
|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4886782A
(en)
|
1987-02-26 |
1989-12-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
Malarial immunogen
|
|
US5433948A
(en)
|
1990-02-13 |
1995-07-18 |
Thomas; Wayne R. |
Cloning and sequencing of allergens of dermatophagoides (house dust mite)
|
|
EP0550599B1
(en)
|
1990-09-27 |
2003-04-23 |
Tripep AB |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
|
EP0623168B1
(en)
|
1991-10-16 |
2009-09-30 |
Merck Patent GmbH |
T cell epitopes of the major allergens from dermatophagoides (house dust mite)
|
|
US7252829B1
(en)
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
US5589582A
(en)
|
1992-10-27 |
1996-12-31 |
Biotransplant, Inc. |
Polynucleotides en coding porcine cytokines
|
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
|
EP0735893B1
(en)
|
1993-09-14 |
2008-11-26 |
Pharmexa Inc. |
Pan dr-binding peptides for enhancement of the immune response
|
|
US5824315A
(en)
|
1993-10-25 |
1998-10-20 |
Anergen, Inc. |
Binding affinity of antigenic peptides for MHC molecules
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
DE69730038T2
(de)
|
1996-08-16 |
2004-11-25 |
The President And Fellows Of Harvard College, Cambridge |
Lösliche monovalente und multivalente mhc klasse ii fusionsproteine und deren verwendungen
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
AU1124499A
(en)
|
1997-10-28 |
1999-05-17 |
Maxygen, Inc. |
Human papillomavirus vectors
|
|
NO315238B1
(no)
|
1998-05-08 |
2003-08-04 |
Gemvax As |
Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
|
|
AR020102A1
(es)
|
1998-07-30 |
2002-04-10 |
Ucb Sa |
Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
|
|
US20030152581A1
(en)
|
1998-07-30 |
2003-08-14 |
Jean-Marie Saint-Remy |
Compound and method for the prevention and/or the treatment of allergy
|
|
CA2350911A1
(en)
|
1998-11-16 |
2000-05-25 |
Board Of Regents, The University Of Texas System |
Hiv-specific t-cell induction
|
|
US7780882B2
(en)
|
1999-02-22 |
2010-08-24 |
Georgetown University |
Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
|
|
EP2333065B1
(en)
|
2000-01-28 |
2017-03-15 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
MHC class II restricted T cell epitopes from the cancer antigen NY ESO-1
|
|
GB0006437D0
(en)
|
2000-03-17 |
2000-05-10 |
Leuven Res & Dev Vzw |
Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens
|
|
AU2001272491A1
(en)
|
2000-06-26 |
2002-01-08 |
Smithkline Beecham Biologicals (S.A.) |
Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
|
|
US7049413B2
(en)
|
2001-05-18 |
2006-05-23 |
Ludwig Institute For Cancer Research |
MAGE-A3 peptides presented by HLA class II molecules
|
|
US20040173778A1
(en)
|
2001-05-30 |
2004-09-09 |
Roncarolo Maria Grazia |
Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof
|
|
EP1432738B1
(en)
|
2001-10-03 |
2009-03-04 |
Unilever N.V. |
Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
|
|
US20100183652A1
(en)
|
2002-02-21 |
2010-07-22 |
Mark Page |
STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS
|
|
WO2003072731A2
(en)
|
2002-02-21 |
2003-09-04 |
Apovia, Inc. |
STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS
|
|
AU2003254950A1
(en)
|
2002-08-26 |
2004-03-11 |
Kirin Beer Kabushiki Kaisha |
Peptides and drugs containing the same
|
|
CN103073620B
(zh)
|
2002-09-12 |
2014-12-10 |
肿瘤疗法科学股份有限公司 |
Kdr肽和包括该肽的疫苗
|
|
JP2004147649A
(ja)
|
2002-10-11 |
2004-05-27 |
Kumamoto Technology & Industry Foundation |
頭頚部癌の抗原
|
|
WO2005012502A2
(en)
|
2003-03-28 |
2005-02-10 |
Idm Pharma, Inc. |
Methods of identifying optimal variants of peptide epitopes
|
|
US7651855B2
(en)
|
2003-04-17 |
2010-01-26 |
The Trustees Of The University Of Pennsylvania |
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
|
|
GB0324265D0
(en)
|
2003-10-16 |
2003-11-19 |
Medical Res Council |
Peptide
|
|
WO2005042575A2
(en)
|
2003-10-30 |
2005-05-12 |
Pharmexa A/S |
Method for down-regulation of vegf
|
|
EP2332971B1
(en)
|
2004-06-17 |
2016-02-17 |
MannKind Corporation |
Epitope analogs
|
|
JP2008044848A
(ja)
|
2004-11-30 |
2008-02-28 |
Univ Kurume |
Ｈｌａ−ａ２４拘束性腫瘍抗原ペプチド
|
|
US8252893B2
(en)
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
WO2007027954A2
(en)
|
2005-08-30 |
2007-03-08 |
Children's Hospital & Research Center At Oakland |
Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
GB0603081D0
(en)
|
2006-02-15 |
2006-03-29 |
Dynal Biotech Asa Oslo |
Method
|
|
FR2898275B1
(fr)
|
2006-03-10 |
2012-12-14 |
Genethon |
Cellules t regulatrices cd4+cd25+specifiques pour la greffe de cellules hematopoietiques et la tolerance immunitaire
|
|
WO2007135684A2
(en)
|
2006-05-22 |
2007-11-29 |
Hadasit Medical Research Services & Development Limited |
Method of treatment of anti-cd4 autoimmunity
|
|
PT2476435T
(pt)
*
|
2006-08-11 |
2018-03-05 |
Life Sciences Res Partners Vzw |
Péptidos imunogénicos e a sua utilização em distúrbios imunitários
|
|
EP2158211B1
(en)
|
2007-05-31 |
2016-08-10 |
Medigene AG |
Mutated structural protein of a parvovirus
|
|
CA2700618A1
(en)
|
2007-09-27 |
2009-04-02 |
The Board Of Trustees Of The University Of Arkansas |
Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor
|
|
WO2009101204A2
(en)
*
|
2008-02-14 |
2009-08-20 |
Life Sciences Research Partners Vzw |
Elimination of immune responses to viral vectors
|
|
AU2009214041A1
(en)
|
2008-02-14 |
2009-08-20 |
Katholieke Universiteit Leuven |
CD4+ T-cells with cytolytic properties
|
|
WO2009101206A2
(en)
|
2008-02-14 |
2009-08-20 |
Life Sciences Research Partners Vzw |
Strategies to prevent and/or treat immune responses to soluble allofactors
|
|
US8999346B2
(en)
|
2008-02-14 |
2015-04-07 |
Life Sciences Research Partners Vzw |
Immunogenic control of tumours and tumour cells
|
|
US9248171B2
(en)
|
2008-02-14 |
2016-02-02 |
Imcyse Sa |
Immunogenic peptides and their use in transplantation
|
|
CA2715611C
(en)
|
2008-02-14 |
2018-03-13 |
Life Sciences Research Partners Vzw |
Immunotherapy targeting intracellular pathogens
|
|
WO2009101201A2
(de)
|
2008-02-15 |
2009-08-20 |
Chemetall Gmbh |
Mischungen aus metallhydriden und ionischen flüssigkeiten und verwendungen solcher mischungen
|
|
WO2009106073A2
(en)
|
2008-02-28 |
2009-09-03 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
KR101022649B1
(ko)
|
2008-08-07 |
2011-03-22 |
삼성모바일디스플레이주식회사 |
헤테로고리 화합물 및 이를 이용한 유기 전계 발광 장치
|
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
CA2756996C
(en)
|
2009-04-01 |
2018-12-11 |
University Of Miami |
Vaccine compositions and methods of use thereof
|
|
GB201002730D0
(en)
|
2010-02-18 |
2010-04-07 |
Uni I Oslo |
Product
|
|
CN103002909B
(zh)
|
2010-03-29 |
2016-06-29 |
国家科学研究中心 |
包含含有至少一个cxxc基序的多肽和异源抗原的药物组合物及其用途
|
|
WO2011147894A1
(en)
|
2010-05-25 |
2011-12-01 |
Forschungsverbund Berlin E.V. |
Chimeric mhc class ii proteinpeptide
|
|
RU2615460C2
(ru)
|
2010-11-25 |
2017-04-04 |
Имнейт Сарл |
Иммуногенные пептиды для применения в профилактике и/или лечении инфекционных заболеваний, аутоиммунных заболеваний, иммунных ответов на аллогенные факторы, аллергических заболеваний, опухолей, отторжения трансплантата и иммунных ответов против вирусных векторов. используемых для генной терапии или генной вакцинации
|
|
GB201201511D0
(en)
|
2012-01-30 |
2012-03-14 |
Univ Leuven Kath |
Modified epitopes for boosting CD4+ T-cell responses
|
|
CN104271148A
(zh)
|
2012-02-15 |
2015-01-07 |
洛桑聚合联合学院 |
红细胞结合性治疗剂
|
|
GB201309469D0
(en)
|
2013-05-28 |
2013-07-10 |
Imcyse Sa |
Detection of CD4+ T lymphocytes
|
|
GB201319160D0
(en)
|
2013-10-30 |
2013-12-11 |
Imcyse Sa |
Methods for induction of antigen-specific regulatory t cells
|
|
GB201418433D0
(en)
|
2014-10-17 |
2014-12-03 |
Imcyse Sa |
Novel immunogenic peptides
|
|
US10729791B2
(en)
|
2015-05-18 |
2020-08-04 |
Imcyse Sa |
Animal models for evaluating pharmaceutical compounds
|
|
EP3352782B1
(en)
|
2015-09-25 |
2021-03-31 |
ImCyse SA |
Improved methods and compounds for eliminating immune responses to therapeutic agents
|
|
KR20240015731A
(ko)
|
2016-04-19 |
2024-02-05 |
임시스 에스에이 |
신규 면역원성 CD1d 결합 펩티드
|